Skip to main content
Subscribe
Register
Sign in
Membership
Events
Knowledge Center
About
Subscribe
Register
Sign in
Premium
Alternative Insight and Premium Journalism
Latest Articles
Premium
Icahn’s Investment Fund Plunges Deeper Into the Red
Stephen Taub
November 8, 2023
Premium
Third Point Slashes Market Exposure
Stephen Taub
November 7, 2023
Premium
Citadel Continues to Set the Pace
Stephen Taub
November 6, 2023
Premium
Valiant Fattens up on Eli Lilly Shares
Stephen Taub
November 2, 2023
Premium
Greenlight Adds to Huge Gains
Stephen Taub
November 1, 2023
Premium
D1, Other Hedgies Eye Biopharma IPO
October 31, 2023
Premium
Groupon’s Next Deal
Stephen Taub
October 30, 2023
Premium
Hedge Funds on Amazon Alert
Stephen Taub
October 26, 2023
Premium
Credit Funds Post Third-Quarter Gains
October 25, 2023
Premium
Hedgies Eye Biopharma IPO
Stephen Taub
October 24, 2023
Premium
This Might Be the Most Volatile Hedge Fund
Stephen Taub
October 23, 2023
Premium
Singh’s Axon Continues to Soar
Stephen Taub
October 19, 2023
Premium
Bridgewater Moves Into the Black
Stephen Taub
October 18, 2023
Premium
A Tiger Grandcub Goes Activist
Stephen Taub
October 17, 2023
Premium
EcoR1 Makes a Timely Bet
Stephen Taub
October 16, 2023
Premium
The Tiger Crowd Sagged in September
Stephen Taub
October 12, 2023
Premium
Amid a Rough Year for Life Sciences, Cormorant Delivers Healthy Returns
Stephen Taub
October 11, 2023
Premium
Why Most of AQR’s Largest Strategies Rose Sharply in September
Stephen Taub
October 10, 2023
More Articles